Vanguard Group
APYX icon

Vanguard Group’s Apyx Medical APYX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.32M Hold
1,475,772
﹤0.01% 3353
2025
Q1
$2.02M Hold
1,475,772
﹤0.01% 3488
2024
Q4
$2.33M Sell
1,475,772
-5,112
-0.3% -$8.08K ﹤0.01% 3520
2024
Q3
$1.84M Hold
1,480,884
﹤0.01% 3587
2024
Q2
$1.98M Hold
1,480,884
﹤0.01% 3553
2024
Q1
$2.01M Hold
1,480,884
﹤0.01% 3590
2023
Q4
$3.88M Buy
1,480,884
+971
+0.1% +$2.54K ﹤0.01% 3384
2023
Q3
$4.74M Hold
1,479,913
﹤0.01% 3273
2023
Q2
$7.44M Sell
1,479,913
-5,516
-0.4% -$27.7K ﹤0.01% 3115
2023
Q1
$4.28M Buy
1,485,429
+70,923
+5% +$204K ﹤0.01% 3383
2022
Q4
$3.31M Buy
1,414,506
+649
+0% +$1.52K ﹤0.01% 3479
2022
Q3
$6.35M Buy
1,413,857
+10,700
+0.8% +$48K ﹤0.01% 3189
2022
Q2
$8.22M Sell
1,403,157
-159,717
-10% -$936K ﹤0.01% 3094
2022
Q1
$10.2M Sell
1,562,874
-12,189
-0.8% -$79.6K ﹤0.01% 3138
2021
Q4
$20.2M Sell
1,575,063
-42,232
-3% -$541K ﹤0.01% 2833
2021
Q3
$22.4M Buy
1,617,295
+61,740
+4% +$855K ﹤0.01% 2806
2021
Q2
$16M Buy
1,555,555
+83,990
+6% +$866K ﹤0.01% 2946
2021
Q1
$14.2M Buy
1,471,565
+40,912
+3% +$395K ﹤0.01% 2964
2020
Q4
$10.3M Buy
1,430,653
+28,039
+2% +$202K ﹤0.01% 2977
2020
Q3
$6.61M Sell
1,402,614
-3,841
-0.3% -$18.1K ﹤0.01% 3009
2020
Q2
$7.81M Sell
1,406,455
-168,113
-11% -$933K ﹤0.01% 2883
2020
Q1
$5.65M Buy
1,574,568
+119,642
+8% +$430K ﹤0.01% 2919
2019
Q4
$12.3M Buy
1,454,926
+30,666
+2% +$259K ﹤0.01% 2759
2019
Q3
$9.64M Buy
1,424,260
+58,004
+4% +$393K ﹤0.01% 2832
2019
Q2
$9.18M Buy
1,366,256
+35,899
+3% +$241K ﹤0.01% 2908
2019
Q1
$8.4M Buy
1,330,357
+41,801
+3% +$264K ﹤0.01% 2918
2018
Q4
$8.35M Buy
1,288,556
+99,222
+8% +$643K ﹤0.01% 2857
2018
Q3
$8.45M Buy
1,189,334
+140,224
+13% +$996K ﹤0.01% 3006
2018
Q2
$4.56M Sell
1,049,110
-183
-0% -$796 ﹤0.01% 3240
2018
Q1
$3.12M Buy
1,049,293
+33,451
+3% +$99.3K ﹤0.01% 3311
2017
Q4
$2.64M Buy
1,015,842
+151,456
+18% +$394K ﹤0.01% 3341
2017
Q3
$2.92M Buy
864,386
+19,977
+2% +$67.5K ﹤0.01% 3295
2017
Q2
$2.09M Buy
844,409
+500
+0.1% +$1.24K ﹤0.01% 3367
2017
Q1
$2.25M Buy
843,909
+30,953
+4% +$82.7K ﹤0.01% 3350
2016
Q4
$2.92M Buy
812,956
+184,034
+29% +$661K ﹤0.01% 3235
2016
Q3
$3.28M Buy
628,922
+88,165
+16% +$459K ﹤0.01% 3193
2016
Q2
$886K Hold
540,757
﹤0.01% 3636
2016
Q1
$903K Buy
540,757
+20,600
+4% +$34.4K ﹤0.01% 3626
2015
Q4
$1.09M Buy
520,157
+24,200
+5% +$50.8K ﹤0.01% 3597
2015
Q3
$982K Buy
495,957
+66,848
+16% +$132K ﹤0.01% 3637
2015
Q2
$1.2M Buy
429,109
+39,553
+10% +$110K ﹤0.01% 3612
2015
Q1
$931K Buy
389,556
+2,100
+0.5% +$5.02K ﹤0.01% 3649
2014
Q4
$1.41M Buy
387,456
+5,642
+1% +$20.5K ﹤0.01% 3412
2014
Q3
$1.52M Buy
381,814
+1,028
+0.3% +$4.1K ﹤0.01% 3369
2014
Q2
$1.38M Buy
380,786
+15,445
+4% +$56.1K ﹤0.01% 3393
2014
Q1
$1.41M Buy
365,341
+20,943
+6% +$80.6K ﹤0.01% 3350
2013
Q4
$730K Hold
344,398
﹤0.01% 3495
2013
Q3
$971K Buy
344,398
+3,400
+1% +$9.59K ﹤0.01% 3377
2013
Q2
$1.01M Buy
+340,998
New +$1.01M ﹤0.01% 3310